Remmie
Remmie Health is a women-founded company that designs and manufactures the Remmie 3, a connected digital otoscope that allows users to capture and share images of their ear, nose, and throat with healthcare providers remotely. This innovative device aims to reduce unnecessary in-person doctor visits, providing significant cost savings and convenience for families. With features like AI-guided image capture and real-time video streaming, Remmie Health positions itself as a leader in telehealth solutions for ENT diagnostics, catering to a wide range of patients from children to older adults. The company has gained traction with a 67% reduction in in-person visits and an average savings of $2,032 per avoided ER visit, making it a compelling investment opportunity in the growing telemedicine market.
Remmie
Remmie Health is a women-founded company that designs and manufactures the Remmie 3, a connected digital otoscope that allows users to capture and share images of their ear, nose, and throat with healthcare providers remotely. This innovative device aims to reduce unnecessary in-person doctor visits, providing significant cost savings and convenience for families. With features like AI-guided image capture and real-time video streaming, Remmie Health positions itself as a leader in telehealth solutions for ENT diagnostics, catering to a wide range of patients from children to older adults. The company has gained traction with a 67% reduction in in-person visits and an average savings of $2,032 per avoided ER visit, making it a compelling investment opportunity in the growing telemedicine market.
TL;DR
Product: FDA-registered consumer digital otoscopes (Remmie 3 and Remmie 4) plus a telehealth app and Remmie.ai
Founded: 2018
Headquarters: Seattle (company described as Seattle-based)
Team size: 19 employees (reported)
Recent funding/grant: NIH/NIDCD SBIR Phase II award announced June 12, 2024 (~$3M)
Company Overview
Problem Domain
Telehealth diagnostics for ear, nose, and throat conditions; at-home ENT imaging to reduce ER and clinic visits.
Founded
2018
Industry
Health technology / Medical devices / Telehealth
Funding Track Record
approximately $3,000,000
Award announced to develop and commercialize Remmie.ai
Investor Signal
“Remmie has received NIH/NIDCD SBIR grant funding and has been listed as having additional investors (Crunchbase reports four investors including Sunstone Management).”